The Gut Microbiome Regulates the Increases in Depressive-type Behaviors and in Inflammatory Processes in the Ventral Hippocampus of Stress Vulnerable Rats
Overview
Psychiatry
Authors
Affiliations
Chronic exposure to stress is associated with increased incidence of depression, generalized anxiety, and PTSD. However, stress induces vulnerability to such disorders only in a sub-population of individuals, as others remain resilient. Inflammation has emerged as a putative mechanism for promoting stress vulnerability. Using a rodent model of social defeat, we have previously shown that rats with short-defeat latencies (SL/vulnerable rats) show increased anxiety- and depression-like behaviors, and these behaviors are mediated by inflammation in the ventral hippocampus. The other half of socially defeated rats show long-latencies to defeat (LL/resilient) and are similar to controls. Because gut microbiota are important activators of inflammatory substances, we assessed the role of the gut microbiome in mediating vulnerability to repeated social defeat stress. We analyzed the fecal microbiome of control, SL/vulnerable, and LL/resilient rats using shotgun metagenome sequencing and observed increased expression of immune-modulating microbiota, such as Clostridia, in SL/vulnerable rats. We then tested the importance of gut microbiota to the SL/vulnerable phenotype. In otherwise naive rats treated with microbiota from SL/vulnerable rats, there was higher microglial density and IL-1β expression in the vHPC, and higher depression-like behaviors relative to rats that received microbiota from LL/resilient rats, non-stressed control rats, or vehicle-treated rats. However, anxiety-like behavior during social interaction was not altered by transplant of the microbiome of SL/vulnerable rats into non-stressed rats. Taken together, the results suggest the gut microbiome contributes to the depression-like behavior and inflammatory processes in the vHPC of stress vulnerable individuals.
Multimodal insights into adult neurogenesis: An integrative review of multi-omics approaches.
Li J, Huang L, Xiao W, Kong J, Hu M, Pan A Heliyon. 2025; 11(4):e42668.
PMID: 40051854 PMC: 11883395. DOI: 10.1016/j.heliyon.2025.e42668.
Kalaga P, Ray S Brain Sci. 2025; 15(2).
PMID: 40002529 PMC: 11852823. DOI: 10.3390/brainsci15020197.
Bertollo A, Santos C, Bagatini M, Ignacio Z Front Neurosci. 2025; 19:1541075.
PMID: 39981404 PMC: 11839829. DOI: 10.3389/fnins.2025.1541075.
Chen L, Zhang K, Liu J, Li X, Liu Y, Ma H Acta Pharm Sin B. 2024; 14(11):4832-4857.
PMID: 39664442 PMC: 11628825. DOI: 10.1016/j.apsb.2024.08.012.
Belnap N, Ramsey K, Carvalho S, Nearman L, Haas H, Huentelman M Brain Sci. 2024; 14(11).
PMID: 39595814 PMC: 11592123. DOI: 10.3390/brainsci14111051.